Rachel Tinker-Kulberg

Dr. Rachel Tinker-Kulberg, the Director of Research and Development at Kepley BioSystems, has brought uncommon expertise to our team. At Kepley, Dr. Tinker-Kulberg is responsible for the development and testing of a new medical diagnostic assay using our proprietary technology. Her expertise in molecular biology, horseshoe crab aquaculture, and sustainable aquafeed formulation led to the production of a marine-derived pharmaceutical product used for the detection and identification of pathogens in human blood for the early treatment of septicemia.

Dr. Tinker-Kulberg earned a Bachelor of Science degree in Biology from the University of South Florida and her PhD in Biology from the University of California, San Diego. Her doctoral studies concentrated on understanding the DNA replication and transcription mechanisms of bacteriophage T4 in E. coli bacteria. Her postdoctoral research at the University of California, San Francisco, then focused on elucidating the mechanisms of DNA damage-induced cell cycle checkpoints in S. cerevisiae yeast.

Dr. Tinker-Kulberg further developed her professional credentials with the Syngenta Group as a senior staff scientist developing plant molecular biopharming techniques for the production of therapeutic recombinant proteins.

Dr. Tinker-Kulberg has also worked as an independent consultant and scientific writer, and she founded her own aquaponics and traditional soil-based urban farm enterprise. Her extensive efforts in community outreach and partnership with local organizations and academic institutions have contributed to community well-being and environmental sustainability through commercial agri-business workshops and nutritional health programs.